Aspen in R5.1bn Latin American drug portfolio acquisition

South African-based multinational pharmaceutical company Aspen Pharmacare will acquire a portfolio of drug products in Latin America from American-based global pharmaceutical company Viatris in a $280 million transaction .

They are getting good products there and it’s well established, and they have already got quite a big presence in the market and I think this scales it up quite nicely,” says McCurrie. “I wouldn’t worry too much about that [share price moves]. I mean they haven’t said what the profitability of the business is or anything like that. I think the market will wait for a bit more information … to see what sort of price they paid for it relative to the profit [potential].

المملكة العربية السعودية أحدث الأخبار, المملكة العربية السعودية عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

Aspen seeks to lift Latin American business in R5bn deal with ViatrisThe drugmaker secured the commercialisation rights and related intellectual property for products such as Viagra and Lipitor
مصدر: BDliveSA - 🏆 12. / 63 اقرأ أكثر »

Aspen grows Latin American assets with R5bn Viagra deal | BusinessSA's biggest pharmaceutical group, Aspen Pharmacare, is deepening its footprint in Latin America with the $280 million (R5 billion) acquisition of a portfolio of specialist drugs, including Viagra. | News24_Business
مصدر: News24 - 🏆 4. / 80 اقرأ أكثر »

Online trading is now a $1bn industry and growing in popularity in SA | City PressToday the local industry is worth about $1 billion per annum and is growing, according to Kamogelo Mosime, partnership manager at Tickmill, an award-winning forex, stock, commodities and bonds broker. Have you made money this way?
مصدر: City_Press - 🏆 7. / 72 اقرأ أكثر »